Literature DB >> 12739016

Corneal confocal microscopy: a non-invasive surrogate of nerve fibre damage and repair in diabetic patients.

R A Malik1, P Kallinikos, C A Abbott, C H M van Schie, P Morgan, N Efron, A J M Boulton.   

Abstract

AIMS/HYPOTHESIS: The accurate detection, characterization and quantification of human diabetic neuropathy are important to define at risk patients, anticipate deterioration, and assess new therapies. Corneal confocal microscopy is a reiterative, rapid, non-invasive in vivo clinical examination technique capable of imaging corneal nerve fibres. The aim of this study was to define the ability of this technique to quantify the extent of degeneration and regeneration of corneal nerve fibres in diabetic patients with increasing neuropathic severity.
METHODS: We scanned the cornea and collected images of Bowman's layer (containing a rich nerve plexus) from 18 diabetic patients and 18 age-matched control subjects.
RESULTS: Corneal nerve fibre density (F(3)=9.6, p<0.0001), length (F(3)=23.8, p<0.0001), and branch density (F(3)=13.9, p<0.0001) were reduced in diabetic patients compared with control subjects, with a tendency for greater reduction in these measures with increasing severity of neuropathy. CONCLUSION/
INTERPRETATION: Corneal confocal microscopy is a rapid, non-invasive in vivo clinical examination technique which accurately defines the extent of corneal nerve damage and repair and acts as a surrogate measure of somatic neuropathy in diabetic patients. It could represent an advance to define the severity of neuropathy and expedite assessment of therapeutic efficacy in clinical trials of human diabetic neuropathy.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12739016     DOI: 10.1007/s00125-003-1086-8

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  32 in total

1.  Sural nerve fibre pathology in diabetic patients with mild neuropathy: relationship to pain, quantitative sensory testing and peripheral nerve electrophysiology.

Authors:  R A Malik; A Veves; D Walker; I Siddique; R H Lye; W Schady; A J Boulton
Journal:  Acta Neuropathol       Date:  2001-04       Impact factor: 17.088

2.  A double-blind placebo-controlled clinical trial of recombinant human brain-derived neurotrophic factor (rhBDNF) in diabetic polyneuropathy.

Authors:  A Wellmer; V P Misra; M K Sharief; P G Kopelman; P Anand
Journal:  J Peripher Nerv Syst       Date:  2001-12       Impact factor: 3.494

3.  Topical treatment with nerve growth factor for corneal neurotrophic ulcers.

Authors:  A Lambiase; P Rama; S Bonini; G Caprioglio; L Aloe
Journal:  N Engl J Med       Date:  1998-04-23       Impact factor: 91.245

4.  Reversal of abnormal corneal epithelial cell morphologic characteristics and reduced corneal sensitivity in diabetic patients by aldose reductase inhibitor, CT-112.

Authors:  H Hosotani; Y Ohashi; M Yamada; K Tsubota
Journal:  Am J Ophthalmol       Date:  1995-03       Impact factor: 5.258

5.  Efficacy and safety of recombinant human nerve growth factor in patients with diabetic polyneuropathy: A randomized controlled trial. rhNGF Clinical Investigator Group.

Authors:  S C Apfel; S Schwartz; B T Adornato; R Freeman; V Biton; M Rendell; A Vinik; M Giuliani; J C Stevens; R Barbano; P J Dyck
Journal:  JAMA       Date:  2000-11-01       Impact factor: 56.272

6.  Incidence of subclinical trigeminal and facial nerve involvement in diabetes mellitus.

Authors:  P P Urban; T Forst; M Lenfers; J Koehler; B J Connemann; J Beyer
Journal:  Electromyogr Clin Neurophysiol       Date:  1999 Jul-Aug

7.  The North-West Diabetes Foot Care Study: incidence of, and risk factors for, new diabetic foot ulceration in a community-based patient cohort.

Authors:  C A Abbott; A L Carrington; H Ashe; S Bath; L C Every; J Griffiths; A W Hann; A Hussein; N Jackson; K E Johnson; C H Ryder; R Torkington; E R E Van Ross; A M Whalley; P Widdows; S Williamson; A J M Boulton
Journal:  Diabet Med       Date:  2002-05       Impact factor: 4.359

8.  Hereditary sensory neuropathy with neurotrophic keratitis. Description of an autosomal recessive disorder with a selective reduction of small myelinated nerve fibres and a discussion of the classification of the hereditary sensory neuropathies.

Authors:  M Donaghy; R N Hakin; J M Bamford; A Garner; G R Kirkby; B A Noble; M Tazir-Melboucy; R H King; P K Thomas
Journal:  Brain       Date:  1987-06       Impact factor: 13.501

9.  Substance P-immunoreactive nerves in the human cornea and iris.

Authors:  K Tervo; T Tervo; L Eränkö; A Vannas; A C Cuello; O Eränkö
Journal:  Invest Ophthalmol Vis Sci       Date:  1982-11       Impact factor: 4.799

10.  Loss and recovery of corneal sensitivity following photorefractive keratectomy for myopia.

Authors:  P J Murphy; M C Corbett; D P O'Brart; S Verma; S Patel; J Marshall
Journal:  J Refract Surg       Date:  1999 Jan-Feb       Impact factor: 3.573

View more
  147 in total

Review 1.  In vivo confocal microscopy of corneal nerves: analysis and clinical correlation.

Authors:  Andrea Cruzat; Deborah Pavan-Langston; Pedram Hamrah
Journal:  Semin Ophthalmol       Date:  2010 Sep-Nov       Impact factor: 1.975

Review 2.  Small-fibre neuropathies--advances in diagnosis, pathophysiology and management.

Authors:  Janneke G Hoeijmakers; Catharina G Faber; Giuseppe Lauria; Ingemar S Merkies; Stephen G Waxman
Journal:  Nat Rev Neurol       Date:  2012-05-29       Impact factor: 42.937

3.  Changes in corneal innervation and sensitivity and acetylcholine-mediated vascular relaxation of the posterior ciliary artery in a type 2 diabetic rat.

Authors:  Eric P Davidson; Lawrence J Coppey; Amey Holmes; Mark A Yorek
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-03-09       Impact factor: 4.799

4.  In vivo three-dimensional confocal laser scanning microscopy of the epithelial nerve structure in the human cornea.

Authors:  Oliver Stachs; Andrey Zhivov; Robert Kraak; Joachim Stave; Rudolf Guthoff
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-08-29       Impact factor: 3.117

5.  Treatment of prediabetic neuropathy.

Authors:  Andrew J M Boulton
Journal:  Curr Diab Rep       Date:  2006-12       Impact factor: 4.810

Review 6.  Diabetic complications in the cornea.

Authors:  Alexander V Ljubimov
Journal:  Vision Res       Date:  2017-04-28       Impact factor: 1.886

7.  Dual-model automatic detection of nerve-fibres in corneal confocal microscopy images.

Authors:  M A Dabbah; J Graham; I Petropoulos; M Tavakoli; R A Malik
Journal:  Med Image Comput Comput Assist Interv       Date:  2010

8.  Poly(ADP-ribose) polymerase inhibition as a novel therapeutic approach against intraepidermal nerve fiber loss and neuropathic pain associated with advanced diabetic neuropathy: a commentary on "PARP Inhibition or gene deficiency counteracts intraepidermal nerve fiber loss and neuropathic pain in advanced diabetic neuropathy".

Authors:  Pal Pacher
Journal:  Free Radic Biol Med       Date:  2008-01-14       Impact factor: 7.376

Review 9.  Epidermal nerve fiber quantification in the assessment of diabetic neuropathy.

Authors:  Kristina K Beiswenger; Nigel A Calcutt; Andrew P Mizisin
Journal:  Acta Histochem       Date:  2008-04-01       Impact factor: 2.479

Review 10.  Diabetic painful and insensate neuropathy: pathogenesis and potential treatments.

Authors:  Irina G Obrosova
Journal:  Neurotherapeutics       Date:  2009-10       Impact factor: 7.620

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.